Your browser doesn't support javascript.
loading
Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22).
Wu, Xilin; Wang, Yaxing; Cheng, Lin; Ni, Fengfeng; Zhu, Linjing; Ma, Sen; Huang, Bilian; Ji, Mengmeng; Hu, Huimin; Li, Yuncheng; Xu, Shijie; Shi, Haixia; Zhang, Doudou; Liu, Linshuo; Nawaz, Waqas; Hu, Qinxue; Ye, Sheng; Liu, Yalan; Wu, Zhiwei.
Afiliação
  • Wu X; Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.
  • Wang Y; Department of Antibody, Abrev Biotechnology Co., Ltd., Nanjing, China.
  • Cheng L; Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, China.
  • Ni F; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
  • Zhu L; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Ma S; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
  • Huang B; Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.
  • Ji M; Department of Antibody, Abrev Biotechnology Co., Ltd., Nanjing, China.
  • Hu H; Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, China.
  • Li Y; Center for Public Health Research, Medical School, Nanjing University, Nanjing, China.
  • Xu S; School of Life Sciences, Ningxia University, Yinchuan, China.
  • Shi H; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang D; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
  • Liu L; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Nawaz W; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
  • Hu Q; Department of Antibody, Y-clone Medical Science Co. Ltd., Suzhou, China.
  • Ye S; Department of Antibody, Y-clone Medical Science Co. Ltd., Suzhou, China.
  • Liu Y; Department of Antibody, Y-clone Medical Science Co. Ltd., Suzhou, China.
  • Wu Z; Department of Antibody, Y-clone Medical Science Co. Ltd., Suzhou, China.
Front Immunol ; 13: 865401, 2022.
Article em En | MEDLINE | ID: mdl-35371009
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / COVID-19 Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / COVID-19 Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China